LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

Home・Aandelen Lijst・Microbot Medical Inc

Microbot Medical Inc

Gesloten

2.54 4.53

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.43

Max

2.61

Belangrijke statistieken
By Trading Economics
Inkomsten	-77K -3.6M
Werknemers	20
EBITDA	-79K -3.6M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+215.13% upside

Dividenden
By Dow Jones
Volgende Winsten	23 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	26M 167M
Vorige openingsprijs	-1.99
Vorige sluitingsprijs	2.54

Technische score

By Trading Central

Vertrouwen

Neutral Evidence

2.52 / 2.57 Steun & Weerstand

Microbot Medical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 mrt 2026, 20:38 UTC

Winsten

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

10 mrt 2026, 23:57 UTC

Marktinformatie

Global Equities Roundup: Market Talk

10 mrt 2026, 23:57 UTC

Marktinformatie

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

10 mrt 2026, 23:47 UTC

Marktinformatie

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

10 mrt 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

10 mrt 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

10 mrt 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

10 mrt 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

10 mrt 2026, 23:35 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

10 mrt 2026, 23:06 UTC

Winsten

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

10 mrt 2026, 22:51 UTC

Belangrijke Nieuwsgebeurtenissen

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

10 mrt 2026, 21:39 UTC

Acquisities, Fusies, Overnames

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

10 mrt 2026, 21:21 UTC

Winsten

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

10 mrt 2026, 21:15 UTC

Winsten

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

10 mrt 2026, 21:15 UTC

Acquisities, Fusies, Overnames

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

10 mrt 2026, 21:14 UTC

Winsten

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

10 mrt 2026, 21:13 UTC

Winsten

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

10 mrt 2026, 21:12 UTC

Winsten

Franco-Nevada 4Q Rev $597.3M >FNV

10 mrt 2026, 21:12 UTC

Winsten

Franco-Nevada 4Q EPS $1.90

10 mrt 2026, 20:57 UTC

Winsten

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mrt 2026, 20:50 UTC

Marktinformatie

Winsten

Tech, Media & Telecom Roundup: Market Talk

10 mrt 2026, 20:44 UTC

Winsten

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mrt 2026, 20:34 UTC

Marktinformatie

Winsten

Global Equities Roundup: Market Talk

10 mrt 2026, 20:34 UTC

Marktinformatie

Winsten

Oracle Building More Software for Less Money After Restructuring -- Market Talk

10 mrt 2026, 20:23 UTC

Winsten

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mrt 2026, 20:16 UTC

Winsten

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

10 mrt 2026, 20:14 UTC

Winsten

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

10 mrt 2026, 20:14 UTC

Winsten

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

10 mrt 2026, 20:13 UTC

Winsten

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

10 mrt 2026, 20:12 UTC

Winsten

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Peer Vergelijking

Prijswijziging

Microbot Medical Inc Prognose

Koersdoel

By TipRanks

215.13% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 7.5 USD 215.13%

Hoogste 12 USD

Laagste 5 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Microbot Medical Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Microbot Medical Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

2.52 / 2.57Steun & Weerstand

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.